vaccination and the highly advanced healthcare facilities to address the growing incidence of
the infection. For instance, as per the Population Reference Bureau (2018), the number of
Americans aged 65 or above are projected to be doubled from 46 million (2016) to 98
million by 2060, with the subsequent rise in the older age group to nearly 24 percent of the
total population from the present 15 percent. The disease is prevalent in older adults usually
between 60 -80 years due to the weak immune system thereby providing an opportunity for
future growth of the market.
European region is the second largest market over the forecast period due to factors such
as the emerging innovative vaccines for disease management and rising incidence of herpes
zoster will provide considerable growth opportunities to herpes zoster treatment companies
in the European region. The growing prevalence of the herpes zoster infection in the regions
such as Asia Pacific and Middle East & Africa which will emerge as the fastest growing
regions in the global herpes zoster infection treatment market.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/herpes-
zoster-market-7137
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Pipeline Products
Chapter 5. Market Factor Analysis
…